glp-1 prescriptions growth slowing 2024 Waistlines and GLP-1s—Expanding in Unison GLP-1 Receptor Agonist Market Growth

Stress-Induced Cortisol Response and Fat Distribution in Women. Obesity Research , vol

Other GLP-1 Agonists Exenatide: The EXSCEL trial (2017) showed a non-significant 9% MACE reduction (HR 0.91, 95% CI 0.831.00) in 14,752 T2DM patients, suggesting modest cardiovascular benefits [17]

M.Gomez-MuozL.Pujol-AutonellI.et al (2020)

Its important to note that GLP-1 injections should be used in conjunction with a healthy diet and regular exercise to achieve the best results

So lets talk a little bit more about that

Talking to my insurance company is not my idea of a good time, but insurance companies are as new to the world of GLP-1s as the rest of us are, and their policies are constantly changing